ProQR Therapeutics (PRQR) FCF Margin Growth (3y) (2016 - 2026)
ProQR Therapeutics (PRQR) FCF Margin Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15,064.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 723.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,409.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | ProQR Therapeutics | 219.53 Mn | 175.72 Mn | - | -739,354.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -739,354.00 |
| Dec 31, 2025 | 231,975.00 |
| Sep 30, 2025 | 143,858.00 |
| Jun 30, 2025 | 125,562.00 |
| Mar 31, 2025 | 146,549.00 |
| Dec 31, 2024 | -225,286.00 |
| Sep 30, 2024 | 76,414.00 |
| Jun 30, 2024 | 397,191.00 |
| Mar 31, 2024 | -22,669.00 |
| Dec 31, 2023 | -7,702.00 |
| Sep 30, 2023 | -50,000.00 |
| Jun 30, 2023 | -58,916.00 |
| Mar 31, 2023 | 682,162.00 |
| Dec 31, 2022 | -260,803.00 |
| Sep 30, 2022 | -179,225.00 |
| Jun 30, 2022 | -148,011.00 |
| Mar 31, 2022 | -175,045.00 |
| Dec 31, 2021 | 191,095.00 |
| Sep 30, 2021 | -83,364.00 |
| Jun 30, 2021 | -401,682.00 |